Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
11 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
BIOPHARMEL from Wemmel, company number BE0505983573, closed financial year 2025 with a result of € -513 after tax. For that financial year BIOPHARMEL recorded a gross margin of € -513 and equity of € -46,276. Compared with financial year 2024, the result moved from € -489 to € -513. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2026.
€ -46,276
▼ € 513 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -513
▼ 5 % more loss than in 2024
Profit after tax over the fiscal year.
€ 6,200
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -52,476.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 513
▼ 44% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -1,028 | € -423 | € -489 | € -513 | ▼ € 24 |
| Profit after taxes | € -1,028 | € -423 | € -489 | € -513 | ▼ € 24 |
| Equity | € -44,850 | € -45,274 | € -45,763 | € -46,276 | ▼ € 513 |
| Total debts | € 51,051 | € 51,474 | € 51,963 | € 52,476 | ▲ 1% |
| Cash | € 6,200 | € 6,200 | € 6,200 | € 6,200 | |
| Retained profit | € -51,050 | € -51,474 | € -51,963 | € -52,476 | ▼ € 513 |
| Balance sheet total | € 6,200 | € 6,200 | € 6,200 | € 6,200 |
Key figures of BIOPHARMEL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIOPHARMEL?
What happened at BIOPHARMEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 513. filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 1,029 loss in 2022 to € 513 loss in 2025.
A new publication or filing at BIOPHARMEL? We notify you, reason included.
Follow BIOPHARMELDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Is. Meyskensstraat 222 box 1A
1780 Wemmel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
All companies at this address →Trippel Invest
€ 46,390 gross margin · 2025
DECOLEM
€ 213,815 gross margin · 2025
BINOT
€ 723,907 gross margin · 2024
Immodestia
€ 291,257 gross margin · 2025
ASK ACCOUNTING
€ 95,820 gross margin · 2025
+6 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0505.983.573
- VAT number
- BE 0505.983.573
- Registered office
- Is. Meyskensstraat 222 bus 1A, 1780 Wemmel
- Names & denominations
- BIOPHARMEL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 December 2014
- Peppol
- Not registered